Teri Ashton received her PhD in Biostatistics from Medical College of Virginia and has been working in the Pharmaceutical Industry for 15 years. She has worked primarily in Oncology and Infectious Diseases, leading innovative clinical trial design discussions across all phases of clinical development. She is interested in exploring new ways to bring efficiencies to drug development in order to make safe and effective medicines available to patients as quickly as possible.